| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad46747489662de7b6bba94b18ef4156 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-321
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-3521 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2015-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_65001ef3e6bef0aecf74b7fbd5f7eb76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_708f53092f459f63b1da2d19817e22ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c63043db0a407e7eddd097b2cd581d14 |
| publicationDate |
2018-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9890379-B2 |
| titleOfInvention |
Treatment of genetic disorders associated with DNA repeat instability |
| abstract |
The current invention provides for methods and medicaments that apply oligonucleotide molecules complementary only to a repetitive sequence in a human gene transcript, for the manufacture of a medicament for the diagnosis, treatment or prevention of a cis-element repeat instability associated genetic disorders in humans. The invention hence provides a method of treatment for cis-element repeat instability associated genetic disorders. The invention also pertains to modified oligonucleotides which can be applied in method of the invention to prevent the accumulation and/or translation of repeat expanded transcripts in cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11525137-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994020-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446387-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11142767-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11479775-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712478-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400163-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10787519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179472-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11555190-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11253607-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10689646-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11707532-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11246941-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11608503-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11274299-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800848-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11497814-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10881743-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576980-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583591-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11311627-B1 |
| priorityDate |
2006-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |